Myasthenia gravis in dogs: muscle weakness and treatment

Overview

The neuromuscular junction is where a motor nerve's signal passes to a muscle cell and triggers muscle activity. The most common form of MG is an acquired autoimmune disease that develops during life. The immune system attacks the body's own structures that receive the signal.

In rarer congenital forms, the structure or function of the neuromuscular junction is genetically abnormal. Distinguishing acquired from congenital disease affects investigations and treatment assessment. Severity ranges from local muscle symptoms to paralysis of the breathing muscles.

The disease affects muscle control even if weakness initially appears in just one activity, such as swallowing or closing the eyelids. Good walking ability therefore does not mean oesophageal function is normal.

Causes

Muscles have difficulty receiving the signal

Motor nerves release acetylcholine, a chemical messenger. Acetylcholine receptors on the muscle cell surface receive this signal. In acquired MG, antibodies destroy these receptors, weakening signal transmission.

The immune reaction may be associated with a thymoma, a tumour of the thymus in the chest. An underactive thyroid or other cancers may also occur alongside MG. A clear underlying cause is not always found.

Acetylcholinesterase is an enzyme that normally breaks down acetylcholine after the signal has passed. The fundamental problem in acquired MG is an antibody reaction against the receptors.

Congenital disease has a different basis

Congenital myasthenic syndromes have been linked to variants in genes including CHRNE, CHAT and COLQ. Some disorders affect signal release, while others affect the space between nerve and muscle or the muscle's receptors.

Congenital myasthenia may be inherited recessively, with a disease-associated variant inherited from each parent.

In the congenital form, there may be too few receptors or they may not work properly.

Risk factors

Acquired myasthenia gravis can develop in any breed. It occurs in both young adult and older dogs. A common older age group is 9–13 years.

The young adult onset group is described as 1–4 or 2–4 years of age.

Congenital symptoms may start as early as 5–10 weeks of age. Puppies are often 6–8 weeks old at onset. A thymus tumour is a recognised associated condition in acquired MG.

However, not every dog with acquired MG has a thymoma.

Typical symptoms

Muscle weakness can vary considerably during the day. Your dog may look almost normal after resting, then tire with even mild activity.

• Your dog tires unusually quickly during a walk or another activity and has to stop.

• The hindlegs or all limbs weaken, and movement may become stiff or trembly.

• Food passively returns to the mouth without the retching and abdominal effort typical of vomiting.

• Swallowing becomes difficult or your dog drools more than usual.

• The bark may change or facial muscles seem weak.

• Eyelid closure or blinking may weaken.

• Neck muscle weakness may make it difficult to hold up the head.

In the localised, or focal, form, weakness may be confined to the facial, throat or oesophageal muscles without obvious limb weakness. In generalised disease, activity often causes stiffness, tremors and weakness. However, weakness is not always associated with exertion.

Even a neurological examination at the practice may be normal between episodes if weakness is intermittent.

Complications and consequences

Oesophageal function and the lungs

In megaoesophagus, the weakened oesophagus dilates and collects food instead of moving it into the stomach. Food or water can enter the airways, causing aspiration pneumonia. Severe or recurrent aspiration pneumonia worsens the outlook.

Pneumonia may cause oxygen deficiency and require intensive care. Rapidly progressing, or fulminant, MG can paralyse the breathing muscles and cause death. The outlook for MG associated with thymoma is more guarded.

Swallowing difficulties may also prevent adequate food and water intake by mouth. In the most severe cases, oxygen deficiency caused by pneumonia may require mechanical ventilation.

The outlook for congenital disease

The outlook for congenital myasthenia is generally more guarded than for acquired disease.

Diagnosis at the vet

Clinical examination and antibodies

The vet examines your dog's movement, muscle strength and general health. Blood tests may include assessment of thyroid function. Measuring serum antibodies against acetylcholine receptors is a key test for acquired MG.

Very early in the disease, the antibody result may be falsely negative. Previous immunosuppressive medication may also affect the result. Raised receptor antibodies are not usually found in congenital disease. A muscle tissue sample may then form part of the investigation.

Listening to the lungs may reveal crackles or areas of reduced breathing sounds. If pneumonia is suspected, an airway sample can be examined for cells, bacterial growth and antimicrobial susceptibility. Cytology of the sample may show neutrophils and bacteria.

Investigations of generalised weakness also rule out cardiovascular and metabolic diseases. Besides chest imaging, abdominal ultrasound may help look for tumours. Electrophysiological tests are performed under anaesthesia.

A precise diagnosis of congenital myasthenia may be investigated with a muscle biopsy or genetic testing of a blood sample. Antibodies measure the immune reaction, while genetic testing looks for an inherited variant.

Drug response and additional investigations

In a test supervised by the vet, improved muscle strength after neostigmine may support the diagnosis. A response may be seen within 30 minutes. The test medicine can cause effects such as drooling, vomiting, diarrhoea and a slow heart rate.

Chest X-rays look for megaoesophagus, aspiration pneumonia and a tumour. Lung changes help assess whether an airway complication already needs treatment. Electrophysiological methods can investigate neuromuscular function when needed.

The test medicine may also increase mucus production in the dog's airways during the investigation.

Treatment

Medication supports signal transmission

Treatment and medicine selection are the vet's responsibility. A commonly used medicine is pyridostigmine, which inhibits the enzyme that breaks down acetylcholine. This lets the messenger act for longer, allowing the remaining receptors to transmit the signal more effectively. If this is insufficient, medicines that suppress the immune response, such as prednisone, may be considered.

An underactive thyroid or another identified associated condition is treated separately. A thymoma can be removed surgically if the dog's condition allows. Complete tumour removal may improve the outlook.

Possible adverse effects of corticosteroids include worsening muscle weakness. Pneumonia risk may also increase, so benefits and risks are assessed for the individual dog. Treatment that removes antibodies from the blood is not widely available for animals.

A CHRNE variant affecting the muscle receptor side can cause a congenital syndrome that responds to an acetylcholinesterase inhibitor.

Swallowing difficulties change feeding needs

A dog with megaoesophagus is fed upright to help food move towards the stomach. The upright position may be maintained for 20–30 minutes after eating to reduce aspiration risk. Food is divided into smaller meals according to the dog's needs. The same food consistency does not suit every dog, so feeding is assessed individually.

If food and water cannot be taken safely, a feeding tube into the stomach may be needed. Aspiration pneumonia may require antibiotics, supplemental oxygen and other hospital care.

In severe aspiration pneumonia, supplemental oxygen helps correct low blood oxygen. Antibiotics may be changed according to airway sample culture and susceptibility results. If pneumonia does not begin to respond within 48–72 hours, the treatment plan is reassessed.

Monitoring and recovery

Improved muscle strength is used to measure treatment response. Monitoring antibody levels every 2–3 months helps guide care. X-rays every 4–6 weeks can monitor improvement in megaoesophagus. Medication may be stopped following veterinary assessment when antibody levels return to the reference range.

Some dogs with acquired disease achieve remission, a symptom-free phase, within a few months. Without severe aspiration pneumonia or significant throat weakness, the outlook for full recovery within 6–8 months may be good. Other dogs need lifelong treatment. The response to medication in congenital disease depends on the precise disorder.

Follow-up X-rays for pneumonia may be taken every 2 weeks, or more often if needed. These monitor lung inflammation, while oesophageal images show how the dilation is changing.

Prevention

There is no known reliable way to prevent myasthenia gravis from developing. In an affected dog, prevention focuses particularly on reducing entry of food and water into the airways. Feeding methods are chosen according to the identified oesophageal and swallowing problems. Do not force your dog to swallow food or medicines if it resists or has difficulty swallowing.

Choosing food consistency individually is part of planning safe feeding.

Aspiration risk also applies when giving medicines if the substance enters the airways instead of being swallowed.

Alongside feeding care, prompt recognition and treatment of pneumonia are central to managing complications.

Important for dog owners

Record how long your dog can manage ordinary daily activities and how rest affects it. Note regurgitation, swallowing problems, voice changes and abnormal breathing too. Take a short video of a typical symptom if you can do so without tiring your dog.

Recording symptoms can help at appointments if your dog looks normal at rest.

Tell the vet about all medicines used before antibody testing. Agree on feeding, drinking and activity limits with your vet. Do not change or stop medication simply because your dog has a good day.

Assessing treatment response includes monitoring the oesophagus and lungs as well as muscle strength.

A dog recovering from pneumonia is examined again during home care too.

Keep a separate feeding record: food consistency, eating position, timing of regurgitation and any cough or breathing change. Bring it to follow-up visits so that practical observations can help assess how well the feeding method works.

Frequently asked questions

Can myasthenia gravis cause only regurgitation?

The focal form may affect the oesophagus, throat or facial muscles without generalised limb weakness. When the oesophagus dilates, food may return to the mouth without actual vomiting. Food or water can still enter the airways. Swallowing and feeding therefore need an individual care plan.

Why does my dog look almost normal after resting?

MG-related muscle weakness can worsen with exertion and improve with rest. Looking well in the morning therefore does not rule out significant neuromuscular junction dysfunction. Stiffness, tremors or the hindlegs giving way may also occur. A video brought to the appointment can illustrate intermittent symptoms.

Does a negative antibody result definitely rule it out?

No: the result can be falsely negative very early in acquired disease. Previous immunosuppressive treatment may also affect testing. Raised antibodies are not usually present in congenital disease, so other investigations are needed.

Can my dog recover completely?

Acquired MG may go into remission within a few months. However, some dogs need lifelong treatment. Repeated or severe aspiration pneumonia worsens the outlook. A thymoma also affects the overall assessment. Muscle strength and antibody levels are used to monitor treatment response.

Is congenital myasthenia in a puppy the same condition?

Both involve a problem with communication between nerve and muscle. However, congenital myasthenic syndromes involve inherited structural or functional abnormalities. Their response to medication depends on the precise type, so treatment for acquired autoimmune disease cannot be applied directly to every puppy.